RankAlpha logo
Back to Rankings

AYTU

Aytu BioPharmaA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-17
View Chart
Current thesis
The constructive case is that EXXUA's first quarter of meaningful launch data was good enough to prove initial demand: 1,300-plus prescriptions, 450-plus unique prescribers, early refill activity, and prior-authorization approvals above 70% suggest the product may have differentiated value in MDD if execution stays disciplined. [#PR-EARNINGS-2026-05-14]
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Cash was $26.7 million at March 31, 2026; if EXXUA ramp or refill trends disappoint, financing risk could return quickly for a micro-cap biotech. [#PR-EARNINGS-2026-05-14]
Momentum
100
Value
69
Sentiment
73
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.80 · Bull $4.00 · Bear $1.20
Data freshness
Prices
As of 2026-07-17
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-17 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-11 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-17
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $9.50
Why
Momentum100 · Δ7d -
Value69 · Δ7d -0.1
Sentiment73 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
100
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
69
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.2
Sentiment
73
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade A. Momentum 99.5 / Value 68.9 / Sentiment 72.7

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$23.08M
Beta
0.37
Shares Out
10.73M
P/E (TTM)
15.7
P/S (TTM)
0.46
P/FCF (TTM) · Derived
6.23
Rev YoY
-32.7%
EPS YoY
-353.1%
Gross Margin
+60.1%
Op Margin
-13.2%
Net Debt
-$8.02M
Current Ratio
1.12
As of 2026-07-17 • Updated nightlySource: Internal modelMethodology